Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Clinical Trials
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lavori, P. W
Right arrow Articles by Dawson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavori, P. W
Right arrow Articles by Dawson, R.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Clinical Trials
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Dynamic treatment regimes: practical design considerations

Philip W Lavori

Stanford University, Stanford, CA, USA; Department of Veterans Affairs Cooperative Studies Program, VA Palo Alto Health Care System (151K), 795 Willow Road, Menlo Park, CA 94025, USAPhilip.Lavori{at}med.va.gov

Ree Dawson

Frontier Science Research Foundation, Boston, MA, USA

Background Clinical management of chronic disease requires a dynamic treatment regime (DTR): rules for choosing the new treatment based on the history of response to past treatments. Estimating and comparing the effects of DTRs from a sample of observed trajectories of treatment and outcome depends on the untestable assumption that new treatments are assigned independently of potential future responses to treatment, conditional on the history of treatments and response to date ("sequential ignorability"). In longitudinal observational studies, sequential ignorability must be assumed, while randomization of dynamic regimes can guarantee it.

Methods Using several clinical examples, we describe the simplest randomized experimental designs for comparing DTRs. We begin by considering an initial treatment A and a second treatment B, and discuss how a dynamic treatment regime that starts with A and leads (sometimes) to B, might be compared to either fixed treatment A or B. We also illustrate the problem of finding the optimal sequence of treatments in a DTR, when there are several choices. We describe and contrast two ways of incorporating randomization into studies to compare such regimes: baseline randomization among DTRs versus randomization at the decision points (sequentially randomized designs).

Conclusions We discuss estimation and inference from both baseline randomized and sequentially randomized designs and conclude with a discussion of the differences between the experimental and observational approaches to optimizing and comparing dynamic treatment regimes.

Clinical Trials, Vol. 1, No. 1, 9-20 (2004)
DOI: 10.1191/1740774504cn002oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
O. Bembom and M. J. van der Laan
Statistical Methods for Analyzing Sequentially Randomized Trials
J Natl Cancer Inst, November 7, 2007; 99(21): 1577 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Clin TrialsHome page
E. Moodie
Letter To The Editor
Clinical Trials, October 1, 2004; 1(5): 471 - 471.
[PDF]



Advertisement